You are here: Industry Insights > CDMO

News List

Vetter Looks Ahead to Further Expansions to Meet Supply Chain Demand B3C newswire
November 06, 2023
Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), announces additional investments as part of its long-term dedication to customer partnerships.
Vetter Earns Frost & Sullivan’s Customer Value Award for the Third Time PharmaSources
August 30, 2023
On August 29, 2023,Vetter has been awarded the Frost & Sullivan’s 2023 Global Customer Value Leadership Award in the aseptic fill-and-finish market for the company’s high performance for its customers.
Samanta Cimitan Appointed Chief Executive Officer (CEO) at Celonic PharmaSources
August 03, 2023
On August 03, 2023，Celonic Group has appointed Dr. Samanta Cimitan as the Chief Executive Officer (CEO) of the Celonic Group, a subsidiary of the independent and privately owned J.RETTENMAIER & Söhne Company (JRS Group).
Vetter Again Demonstrates Industry Leadership in Sustainability Initiatives PharmaSources
June 15, 2023
On June 14, 2023,Vetter, one of the world's leading Contract Development and Manufacturing Organizations, is consistently pursuing improvements to its sustainability strategy.
High Demand: Vetter Expands Production Capacities and Services Offered at Its Austrian Site PharmaSources
May 10, 2023
Vetter has completed the first year of production in Rankweil successfully and is preparing to further increase production capacities and capabilities on site.
Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market PharmaSources
February 02, 2023
Both the US Skokie and European Rankweil sites address customer needs in early-phase drug development
Chinese CDMO Asymchem Expands US Footprint contractpharma
February 11, 2022
Acquires Snapdragon Chemistry for $58 million.
TriRx Completes Acquisition of Elanco Manufacturing Facility contractpharma
February 09, 2022
The Speke, UK facility offers capabilities to manufacture human health and animal health products.
Olon Expands High Containment API Operations contractpharma
February 09, 2022
The CDMO plans to invest €27 million over the next two years including a newly commissioned production line.
MilliporeSigma Reorganizes and Adopts New Operating Model contractpharma
February 09, 2022
Aims to support the long-term growth strategy of the Life Science business sector.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page